Publications - Nicholas J . Talley, M.D.

Back to Research Profile

1. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil 2009 Dec; 21(Suppl 2):1-8.
   View PubMed
2. Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil 2009 Dec; 21(Suppl 2):41-54.
   View PubMed
3. Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H. Marked Deposition of Eosinophil-Derived Neurotoxin in Adult Patients With Eosinophilic Esophagitis. Am J Gastroenterol 2009 Nov 03. [Epub ahead of print]
   View PubMed
4. Eslick GD, Kalantar JS, Talley NJ. Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study. Colorectal Dis 2009 Nov; 11(9):921-6.
   View PubMed
5. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis 2009 Nov; 41(11):772-80. Epub 2009 Aug 08.
   View PubMed
6. Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE. Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol 2009 Nov-Dec; 43(10):933-40.
   View PubMed
7. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-Predominant Irritable Bowel Syndrome Is Associated With Diverticular Disease: A Population-Based Study. Am J Gastroenterol 2009 Oct 27. [Epub ahead of print]
   View PubMed
8. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, Talley NJ, Diehl NN, Beebe TJ, Harris AM, Farrugia G, Graner DE, Murray JA, Locke GR 3rd, Grothe RM, Crowell MD, Francis DL, Grudell AM, The Mayo Dysphagia Questionnaire-30: Documentation of Reliability and Validity of a Tool for Interventional Trials in Adults with Esophageal Disease. Dysphagia 2009 Oct 24. [Epub ahead of print]
   View PubMed
9. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Onset and Risk Factors for Fecal Incontinence in a US Community. Am J Gastroenterol 2009 Oct 20. [Epub ahead of print]
   View PubMed
10. Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ. A Randomized, Double-Blind, Placebo-Controlled Trial of St John's Wort for Treating Irritable Bowel Syndrome. Am J Gastroenterol 2009 Oct 06. [Epub ahead of print]
    View PubMed
11. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther 2009 Oct 1; 30(7):775-83.
    View PubMed
12. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Bui HH, Kachintorn U, Goh KL, Chiba T, Rani AA. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009 Oct; 24(10):1587-600.
    View PubMed
13. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol 2009 Oct; 24(Suppl 3):S20-8.
    View PubMed
14. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol 2009 Oct; 24 Suppl 3:S20-8.
    View PubMed
15. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil 2009 Oct; 21(10):NIL_42-50.
    View PubMed
16. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther 2009 Oct; 30(7):775-83. Epub 2009 Jun 25.
    View PubMed
17. Saito YA, Talley NJ. AJG series: molecular biology for clinicians. Am J Gastroenterol 2009 Oct; 104(10):2583-7. Epub 2009 Jun 23.
    View PubMed
18. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, Locke GR 3rd, Talley NJ. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009 Oct; 7(10):1055-61. Epub 2009 Jul 01.
    View PubMed
19. Chang JY, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil 2009 Oct; 21(10):1060-e87. Epub 2009 May 21.
    View PubMed
20. Talley NJ. Pathogenesis of Irritable Bowel Syndrome: Are Genes a SERT-ainty? J Clin Gastroenterol 2009 Sep 01. [Epub ahead of print]
    View PubMed
21. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol 2009 Sep; 6(9):524-32.
    View PubMed
22. Gathaiya N, Locke GR, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009 Sep; 21(9):NIL_12-8.
    View PubMed
23. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol 2009 Sep; 6(9):524-32.
    View PubMed
24. Gathaiya N, Locke Iii GR, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02.
    View PubMed
25. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol 2009 Jul; 104(7):1772-9. Epub 2009 Jun 02.
    View PubMed
26. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Bjorck E, Lind T, Bolling-Sternevald E. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol 2009 Jul; 7(7):756-61.
    View PubMed
27. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009 Jul; 137(1):94-100.
    View PubMed
28. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther 2009 Jun 25. [Epub ahead of print]
    View PubMed
29. Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol 2009 Jun; 104(6):1339-41.
    View PubMed
30. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol 2009 May; 104(5):1199-204. Epub 2009 Apr 14.
    View PubMed
31. Goodwin RD, Keyes KM, Stein MB, Talley NJ. Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med 2009 May; 71(4):463-8.
    View PubMed
32. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Wolfsen H, Raimondo M, Guarderas JC, Achem SR. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009 Apr; 104(4):828-33. Epub 2009 Feb 24.
    View PubMed
33. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009 Apr; 136(4):1225-33. Epub 2008 Dec 24.
    View PubMed
34. Money ME, Hofmann AF, Hagey LR, Walkowiak J, Talley NJ. Treatment of Irritable Bowel Syndrome-Diarrhea With Pancrealipase or Colesevelam and Association With Steatorrhea. Pancreas 2009 Mar; 38(2):232-233.
    View PubMed
35. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond) 2009 Mar; 33(3):342-53. Epub 2009 Jan 13.
    View PubMed
36. Talley NJ, Seon Choung R. Functional (non-ulcer) dyspepsia and gastroparesis--differentiating these conditions and practical management approaches. Rev Gastroenterol Disord 2009 Spring; 9(2):E48-53.
    View PubMed
37. Talley NJ. Risks of proton-pump inhibitors: what every doctor should know. Med J Aust 2009 Feb 2; 190(3):109-10.
    View PubMed
38. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
39. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol 2009 Feb; 43(2):111-7.
    View PubMed
40. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol 2009 Feb; 296(2):G211-8. Epub 2008 Dec 04.
    View PubMed
41. Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol 2009 Jan; 7(1):9-19. Epub 2008 Oct 01.
    View PubMed
42. American College of Gastroenterology Task Force on Irritable Bowel, Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009 Jan; 104 Suppl 1:S1-35.
    View PubMed
43. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009 Jan; 104 Suppl 1:S1-35.
    View PubMed
44. Agreus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol 2009; 44(5):564-70.
    View PubMed
45. Rex DK, Talley NJ, Katz PO, Sandborn WJ, Hanauer SB. Report From the ACG: Highlights of the 72nd Annual Scientific Meeting of the American College of Gastroenterology, October 12-17, 2007, Philadelphia, PA. Rev Gastroenterol Disord 2008 Winter; 8(1):42-57.
    View PubMed
46. Ford AC, Talley NJ, Spiegel BMR, Foxx-Orenstein AE, Schiller L, Quigley EMM, Moayyedi P. Effect of fibre, antispasmodics and peppermint oil in the treatment of irritable bowel syndrome: system review and meta-analysis. BMJ 2008 Nov 13; 337:A2313.
    View PubMed
47. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol 2008 Nov 1; 102(9):1207-11. Epub 2008 Aug 27.
    View PubMed
48. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 2008 Nov; 57(11):1545-53. Epub 2008 Aug 01.
    View PubMed
49. Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scan J Gastroenterol 2008 Nov:1-7.
    View PubMed
50. Talley NJ. Genetics and functional bowel disease. J Pediatr Gastroenterol Nutr 2008 Nov; 47(5):680-2.
    View PubMed
51. Ford AC, Talley NJ, van Zanten SJOV, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 2008 Oct 15; 300(15):1793-805.
    View PubMed
52. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 2008 Oct; 103(10):2613-23. Epub 2008 Sep 04.
    View PubMed
53. Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 2008 Oct; 83(10):1087-94.
    View PubMed
54. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 2008 Oct; 103(10):2613-23. Epub 2008 Sep 04.
    View PubMed
55. Talley NJ. Reply to Dr. Kittisupamongkol. Am J Gastroenterol 2008 Sep 04. [Epub ahead of print]
    View PubMed
56. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol 2008 Sep; 20(9):888-97.
    View PubMed
57. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil 2008 Sep; 20(9):989-97.
    View PubMed
58. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol 2008 Sep; 20(9):888-97.
    View PubMed
59. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil 2008 Sep; 20(9):989-97. Epub 2008 May 06.
    View PubMed
60. Talley NJ. RESPONSE TO THE LETTER. Am J Gastroenterol 2008 Aug 27. [Epub ahead of print]
    View PubMed
61. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther 2008 Aug 1; 28(3):334-43.
    View PubMed
62. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: Results of two randomized, controlled trials. Am J Gastroenterol 2008 Aug; 103(8):1906-19.
    View PubMed
63. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: Associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol 2008 Aug; 103(8):2023-30.
    View PubMed
64. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol 2008 Aug; 103(8):2051-60.
    View PubMed
65. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol 2008 Aug; 103(8):1906-19. Epub 2008 Jul 04.
    View PubMed
66. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol 2008 Aug; 103(8):2023-30.
    View PubMed
67. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol 2008 Aug; 103(8):2051-60.
    View PubMed
68. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2008 Aug; 103(8):2043-50.
    View PubMed
69. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol 2008 Aug; 103(8):2100-4; quiz 2105. Epub 2008 Jul 05.
    View PubMed
70. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc 2008 Aug; 68(2):301-7. Epub 2008 Feb 11.
    View PubMed
71. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, Argreus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008 Jul 29; Scand J Gastroenterol. 2008 Jul 29:1-8.
    View PubMed
72. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil 2008 Jul; 20(7):790-7.
    View PubMed
73. Shah ND, Chitkara DK, Locke GR, Meek PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol 2008 Jul; 103(7):1746-53. Epub 2008 Jun 28.
    View PubMed
74. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07.
    View PubMed
75. Talley NJ. Chronic unexplained diarrhea: what to do when the initial workup is negative? Rev Gastroenterol Disord 2008 Summer; 8(3):178-85.
    View PubMed
76. Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am 2008 Jun; 37(2):383-95, vi.
    View PubMed
77. Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med 2008 Jun; 8(4):253-7.
    View PubMed
78. Prasad GA, Talley NJ. Eosinophilic esophagitis in adults. Gastroenterol Clin North Am 2008 Jun; 37(2):349-68, v-vi.
    View PubMed
79. Talley NJ. Gut eosinophilia in food allergy and systemic and autoimmune diseases. Gastroenterol Clin North Am 2008 Jun; 37(2):307-32, v.
    View PubMed
80. Talley NJ. Eosinophilic and autoimmune gastrointestinal disease: new insights and new entities. Preface. Gastroenterol Clin North Am 2008 Jun; 37(2):xi-xii.
    View PubMed
81. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut 2008 Jun; 57(6):756-63.
    View PubMed
82. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008 Jun; 57(6):740-6. Epub 2007 Oct 26.
    View PubMed
83. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008 May; 20 Suppl 1:121-9.
    View PubMed
84. Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguere M, Horowitz M, Jones KL. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil 2008 May; 20(5):456-63. Epub 2008 Jan 07.
    View PubMed
85. Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther 2008 May; 27(10):971-9. Epub 2008 Feb 28.
    View PubMed
86. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol 2008 May; 103(5):1241-8. Epub 2008 Apr 16.
    View PubMed
87. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: A population-based cohort study. Aliment Pharmacol Ther 2008 Apr 13. [Epub ahead of print]
    View PubMed
88. Haag S, Senf W, Hauser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther 2008 Apr 1; 27(7):561-71. Epub 2008 Jan 16.
    View PubMed
89. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg 2008 Apr; 18(4):401-7. Epub 2008 Feb 20.
    View PubMed
90. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol 2008 Apr; 103(4):820-2.
    View PubMed
91. Talley NJ. Commentary: Controversies in NICE guidance on irritable bowel syndrome. BMJ 2008 Mar 8; 336(7643):558-9.
    View PubMed
92. Choung RS, Ferguson DD, Murray JA, Kammer PP, Dierkhising RA, Zinsmeister AR, Nurbhai S, Landau SB, Talley NJ. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. Aliment Pharmacol Ther 2008 Mar 1; 27(5):404-11. Epub 2007 Dec 11.
    View PubMed
93. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008 Mar; 103(3):510-4.
    View PubMed
94. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil 2008 Mar; 20(3):220-7. Epub 2007 Nov 20.
    View PubMed
95. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008 Mar; 23(3):351-65.
    View PubMed
96. Moayyedi P, Burch N, Akhtar-Danesh N, Enagantit SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Alimentary Pharmacology & Therapeutics 2008 Feb 15; 27(4):316-20.
    View PubMed
97. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther 2008 Feb 15; 27(4):316-20. Epub 2007 Dec 06.
    View PubMed
98. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol 2008 Feb; 42(2):160-6.
    View PubMed
99. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-Levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works? Gastrointest Endosc 2008 Feb; 67(2):297-303. Epub 2007 Oct 29.
    View PubMed
100. Achkar E, Richter JE, Talley NJ. Conflict of interest policy of the American Journal of Gastroenterology: new and improved. Am J Gastroenterol 2008 Feb; 103(2):25.
     View PubMed
101. Achkar E, Richter JE, Talley NJ. American Journal of Gastroenterology conflict of interest policy. Am J Gastroenterol 2008 Feb; 103(2):260-1.
     View PubMed
102. Talley NJ. Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori. ACP J Club 2008 Jan-Feb; 148(1):10.
     View PubMed
103. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci 2008 Jan; 53(1):108-15. Epub 2007 May 15.
     View PubMed
104. Tuteja AK, Talley NJ, Gelman SS, Adler SC, Thompson C, Tolman K, Hale DC. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008 Jan; 53(1):271-6.
     View PubMed
105. Talley NJ, Locke GR 3rd, McNally M, Schleck CD, Zinsmeister AR, Melton LJ 3rd. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol 2008 Jan; 103(1):12-9. Epub 2007 Sep 26.
     View PubMed
106. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S, Lin SR, Wong BC, Chan FK, Rani AA, Bak YT, Sollano J, Ho KY, Manatsathit S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008 Jan; 23(1):8-22.
     View PubMed
107. Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making 2008 Jan-Feb; 28(1):44-55. Epub 2007 Dec 05.
     View PubMed
108. Tuteja AK, Talley NJ, Gelman SS, Alder SC, Thompson C, Tolman K, Hale DC. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008 Jan; 53(1):271-6. Epub 2007 Jun 05.
     View PubMed
109. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley N, Engstrand L, Stolte M, Vieth M, Walker M, Agreus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008; 43(12):1448-55.
     View PubMed
110. Talley NJ. Gastric cancer concensus conference recommends H. pylori screening and treatment in asymptomatic persons from high risk populations to prevent gastric cancer Am J Gastroenterol 510-4 2008; 103(3):510-4.
     View PubMed
111. Talley NJ. Subdividing functional dyspepsia: A paradigm shift? Gut 2008; 57(1):1487-9.
     View PubMed
112. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, Agreus L. Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis 2008; 26(3):256-63. Epub 2008 May 07.
     View PubMed
113. Agreus L, Talley NJ, Sheen A, Johansson SE, Jones MP, Svardsudd K. Predictors and non-predictors of symptom relief in dyspepsia consultations in primary care. Dig Dis 2008; 26(3):248-55. Epub 2008 May 07.
     View PubMed
114. Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of dyspepsia: will it help research? Dig Dis 2008; 26(3):203-9. Epub 2008 May 06.
     View PubMed
115. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, Agréus L. Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis 2008; 26(3):256-63.
     View PubMed
116. Agréus L, Talley NJ, Sheen A, Johansson SE, Jones MP, Svardsudd K. Predictors and non-predictors of symptom relief in dyspepsia consultations in primary care. Dig Dis 2008; 26(3):248-55.
     View PubMed
117. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007 Dec; 102(12):2627-32. Epub 2007 Aug 31.
     View PubMed
118. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther 2007 Dec; 26(11-12):1521-8. Epub 2007 Oct 05.
     View PubMed
119. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med 2007 Nov; 23(4):721-34, v.
     View PubMed
120. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil 2007 Nov; 19(11):905-11.
     View PubMed
121. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Epidemiology of slow and fast colonic transit using a scale of stool form in a community. Aliment Pharmacol Ther 2007 Oct 1; 26(7):1043-50.
     View PubMed
122. Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR, Agreus L. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007 Oct; 5(10):1175-83. Epub 2007 Aug 07.
     View PubMed
123. Levy RL, Finch EA, Crowell MD, Talley NJ, Jeffery RW. Behavioral intervention for the treatment of obesity: strategies and effectiveness data. Am J Gastroenterol 2007 Oct; 102(10):2314-21. Epub 2007 Jun 11.
     View PubMed
124. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of Intestinal Metaplasia in Barrett's Esophagus. Am J Gastroenterol 2007 Oct; 102(10):2353-4.
     View PubMed
125. Talley NJ, Li Z. Helicobacter pylori: testing and treatment. Expert Rev Gastroenterol Hepatol 2007 Oct; 1(1):71-9.
     View PubMed
126. Talley NJ. Introducing Expert Review of Gastroenterology and Hepatology. Expert Rev Gastroenterol Hepatol 2007 Oct; 1(1):1-2.
     View PubMed
127. van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE, STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther 2007 Sep 1; 26(5):665-72.
     View PubMed
128. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Bjorck E, Lind T, STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther 2007 Sep 1; 26(5):673-82.
     View PubMed
129. Talley NJ. Functional nausea and vomiting. Aust Fam Physician 2007 Sep; 36(9):694-7.
     View PubMed
130. Chitkara DK, Talley NJ, Locke GR 3rd, Weaver AL, Katusic SK, De Schepper H, Rucker MJ. Medical presentation of constipation from childhood to early adulthood: a population-based cohort study. Clin Gastroenterol Hepatol 2007 Sep; 5(9):1059-64. Epub 2007 Jul 13.
     View PubMed
131. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007 Sep; 133(3):799-807. Epub 2007 Jun 20.
     View PubMed
132. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007 Sep; 102(9):1983-9. Epub 2007 Jun 20.
     View PubMed
133. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther 2007 Aug 1; 26(3):453-61.
     View PubMed
134. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol 2007 Aug; 102(8):1596-602. Epub 2007 Apr 24.
     View PubMed
135. Halder SL, Talley NJ. Functional Dyspepsia: A New Rome III Paradigm. Curr Treat Options Gastroenterol 2007 Aug; 10(4):259-72.
     View PubMed
136. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther 2007 Jun 1; 25(11):1343-50.
     View PubMed
137. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007 Jun; 102(6):1154-61. Epub 2007 Apr 13.
     View PubMed
138. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2007 Jun; 19(6):465-70.
     View PubMed
139. Cash BD, Chang E, Talley NJ, Wald A. Fresh perspectives in chronic constipation and other functional bowel disorders. Rev Gastroenterol Disord 2007 Summer; 7(3):116-33.
     View PubMed
140. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2007 May; 56(5):615-20.
     View PubMed
141. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol 2007 May; 5(5):534-40. Epub 2007 Apr 11.
     View PubMed
142. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther 2007 Apr 15; 25(8):973-86.
     View PubMed
143. Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2007 Apr 1; 25(7):813-21.
     View PubMed
144. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 Mar; 132(3):913-20.
     View PubMed
145. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil 2007 Mar; 19(3):180-7.
     View PubMed
146. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord 2007 Spring; 7(2):97-105.
     View PubMed
147. McNally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastroenterol 2007 Mar; 10(2):157-68.
     View PubMed
148. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther 2007 Feb 15; 25(4):447-53.
     View PubMed
149. Crane SJ, Locke GR, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther 2007 Feb 15; 25(4):447-53.
150. Liebregts T, Adam B, Bertel A, Lackner C, Neumann J, Talley NJ, Gerken G, Holtmann G. Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain 2007 Feb; 11(2):216-22.
     View PubMed
151. Chitkara DK, Talley NJ, Weaver AL, Katusic SK, De Schepper H, Rucker MJ, Locke GR 3rd. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin Gastroenterol Hepatol 2007 Feb; 5(2):186-91.
     View PubMed
152. Richter JE, Talley NJ. American Journal of Gastroenterology 2006: The Best Clinical GI Journal in the World. Am J Gastroenterol 2007 Feb; 102(2):229-31.
     View PubMed
153. Talley NJ. How to manage the difficult-to-treat dyspeptic patient. Nat Clin Pract Gastroenterol Hepatol 2007 Jan; 4(1):35-42.
     View PubMed
154. Bueno L, De Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EMM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil 2007 Jan; 19(Suppl 1):89-119.
     View PubMed
155. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant 2007 Jan; 47(1):81-3, 87-8, 89-90.
     View PubMed
156. Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Langstrom G, Naesdal J, Yeomans ND, NASA/SPACE author group. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther 2007; 9(1):R17.
     View PubMed
157. Grudell AB, Alexander JA, Enders FB, Pacifico R, Fredericksen M, Wise JL, Locke GR 3rd, Arora A, Zais T, Talley NJ, Romero Y. Validation of the Mayo Dysphagia Questionnaire. Dis Esophagus 2007; 20(3):202-5.
     View PubMed
158. Choung RS, Talley NJ. Food allergy and intolerance in IBS. J Gastroenterol Hepatol 2007; 2:756-60.
     View PubMed
159. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML. Best of DDW 2007. Rev Gastroenterol Disor 2007; 7(3):134-66.
     View PubMed
160. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol 2006 Dec; 101(12):2848-56; quiz 2914. Epub 2006 Oct 06.
     View PubMed
161. Talley NJ. Irritable bowel syndrome. Intern Med J 2006 Nov; 36(11):724-8.
     View PubMed
162. Cremonini F, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil 2006 Nov; 18(11):987-94.
     View PubMed
163. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil 2006 Nov; 18(11):1001-8.
     View PubMed
164. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol 2006 Nov; 101(11):2449-52.
     View PubMed
165. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol 2006 Oct; 18(10):1101-9.
     View PubMed
166. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006 Aug; 131(2):390-401; quiz 659-60.
     View PubMed
167. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter 2006 Aug; 11(4):224-30.
     View PubMed
168. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2006 Jul 15; 24(2):371-6.
     View PubMed
169. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2006 Jul 15; 24(2):405-10.
     View PubMed
170. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2006 Jul 1; 24(1):55-63.
     View PubMed
171. Talley NJ, Locke GR 3rd, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006 Jul; 55(7):933-9. Epub 2005 Dec 01.
     View PubMed
172. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc) 2006 Jul; 42 Suppl B:3-8.
     View PubMed
173. Chitkara DK, Bredenoord AJ, Talley NJ, Whitehead WE. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol 2006 Jul; 9(4):305-13.
     View PubMed
174. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006 Jun 24; 367(9528):2086-100.
     View PubMed
175. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther 2006 Jun 15; 23(12):1725-33.
     View PubMed
176. Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther 2006 Jun 15; 23(12):1749-55.
     View PubMed
177. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, Stolte M, Talley NJ, Agreus L. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006 Jun 1; 163(11):1025-34. Epub 2006 Mar 22.
     View PubMed
178. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology 2006 Jun; 130(7):1985-94.
     View PubMed
179. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol 2006 Jun; 41(6):657-66.
     View PubMed
180. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol 2006 Jun; 101(6):1379-89.
     View PubMed
181. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA. Best of DDW 2006. Rev Gastroenterol Disord 2006 Summer; 6(3):153-89.
     View PubMed
182. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D'Elia TV, Tack J, Earnest DL. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther 2006 Apr 1; 23(7):923-36.
     View PubMed
183. Talley NJ. How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Nat Clin Pract Gastroenterol Hepatol 2006 Apr; 3(4):196-7.
     View PubMed
184. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FKL, Tulassay Z, Ralnoldi JL, Szczepanski L, Ung JA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006 Apr; 101(4):701-10.
     View PubMed
185. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology 2006 Apr; 130(5):1466-79.
     View PubMed
186. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, van Zanten SJOV. Design of treatment trials for functional gastrointestinal disorders. Gastroenterol 2006 Apr; 130(5):1538-51.
     View PubMed
187. Tally NJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation, and diagnosis... includes discussion. Advanced Studies in Medicine 2006 Apr; 6(4A):S225-31, S251-3.
188. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006 Apr; 130(5):1538-51.
     View PubMed
189. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006 Apr; 101(4):701-10. Epub 2006 Feb 22.
     View PubMed
190. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther 2006 Mar 15; 23(6):683-90.
     View PubMed
191. Talley NJ. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord 2006 Spring; 6(2):72-8.
     View PubMed
192. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006 Feb 23; 354(8):832-40.
     View PubMed
193. Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol 2006 Feb; 101(2):211.
     View PubMed
194. Fajardo NR, Wise JL, Locke GR 3rd, Murray JA, Talley NJ. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc 2006 Jan; 63(1):184-5.
     View PubMed
195. Boyce PM, Talley NJ, Burke C, Koloski NA. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J 2006 Jan; 36(1):28-36.
     View PubMed
196. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006; 295:1566-76.
     View PubMed
197. Talley NA, Talley NJ. Hepatitis C: diagnosis and management issues. Australian Defense Force Health 2006; 7:22-8.
     View PubMed
198. Stolte M, Muller H, Talley NJ, O'morain C, Bolling-Sternevald E, Sundin M, Eriksson S, Blum A. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. Pathol Res Pract 2006; 202(6):405-13. Epub 2006 May 05.
     View PubMed
199. Hancox RJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, Cowan JO, Flannery EM, Herbison GP, Sears MR, Talley NJ. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res 2006; 7:142. Epub 2006 Dec 05.
     View PubMed
200. Rex DK, Talley NJ, Katz PO, Hanauer SB, Sandborn WJ. Report from the ACG: Highlights of the 71st Annual Scientific Meeting of the American College of Gastroenterology, October 20-25, Las Vegas, NV. Reviews in Gastroenterological Disorders 2006; 6(4):227-42.
     View PubMed
201. Fajardo NR, Cremonini F, Talley NJ. Management of constipation in patients with cancer. Am J Cancer 2006; 5(5):319-30.
     View PubMed
202. Choung RS, Talley NJ. Food allergy and intolerance in IBS. Gastroenterol. Hepatol 2006; 2(10):756-60.
     View PubMed
203. Rex DK, Hanauer SB, Sandborn WJ, Katz PO, Talley NJ. Report from the ACG. Highlights of the 70th Annual Scientific Meeting of the American College of Gastroenterology October 28-November 2, 2005, Honolulu, HI. Reviews in Gastroenterological Disorders 2006; 6(1):35-47.
     View PubMed
204. Talley N. Stop your intestines from rebelling. Bottom Line/Health 2005 Dec; 19(12):5-6.
205. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: A population-based case-control study. Am J Gastroenterol 2005 Dec; 100(12):2743-8.
     View PubMed
206. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology 2005 Dec; 129(6):1825-31.
     View PubMed
207. Yeomans ND, Lanas AI, Talley NJ, Thomson ABR, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005 Nov 1; 22(9):795-801.
     View PubMed
208. Chitkara DK, Bredenoord AJ, Rucker MJ, Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther2005 Nov 1; 22(9):855-8.
     View PubMed
209. Wise JL, Locke GR, Zinsmeister AR, Talley NJ. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther 2005 Nov; 22(10):1023-31.
     View PubMed
210. Saito YA, Petersen GM, Locke GR, Talley NJ. The genetics of irritable bowel syndrome. Clinical Gastroenterology & Hepatology 2005 Nov; 3(11):1057-65.
     View PubMed
211. Talley NJ. Review: prompt endoscopy is not a cost-effective strategy for initial management of dyspepsia. ACP J Club 2005 Nov-Dec; 143(3):76.
     View PubMed
212. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005 Nov; 129(5):1756-80.
     View PubMed
213. Eslick GD, Coulshed DS, Talley NJ. Diagnosis and treatment of noncardiac chest pain. Nat Clin Pract Gastroenterol Hepatol 2005 Oct; 2(10):463-72.
     View PubMed
214. Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 2005 Oct; 54(10):1377-83.
     View PubMed
215. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005 Oct; 100(10):2324-37.
     View PubMed
216. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: Birth-cohort study. Am J Gastroenterol 2005 Sep; 100(9):2071-8.
     View PubMed
217. Ahlawat SK, Locke GR, Weaver AL, Farmer SA, Yawn BP, Talley NJ. Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther 2005 Aug 1; 22(3):251-9.
     View PubMed
218. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol 2005 Aug; 289(2):G261-6.
219. Chitkara DK, Bredenood AJ, Wang M, Rucker MJ, Talley NJ. Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterol Motil 2005 Aug; 17(4):518-22.
     View PubMed
220. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: A systematic review. Am J Gastroenterol 2005 Aug; 100(8):1868-75.
     View PubMed
221. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep 2005 Aug; 7(4):289-96.
     View PubMed
222. Nandurkar S, Locke GR, Murray JA, Melton LJ, Zinsmeister AR, Dierkhising R, Talley NJ. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol 2005 Jul; 100(7):1459-65.
     View PubMed
223. Fawcett JP, Barbezat GO, Poulton R, Milne BJ, Xia HH, Talley NJ. Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol 2005 Jun 7; 11(21):3273-6.
     View PubMed
224. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A metaanalysis. Am J Gastroenterol 2005 Jun; 100(6):1226-32.
     View PubMed
225. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005 Jun; 3(6):543-52.
     View PubMed
226. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005 Jun; 34(2):189-204.
     View PubMed
227. Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJY, Langstrom G, Naesdal J, Scheiman JM. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol 2005 May; 100(5):1028-36.
     View PubMed
228. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol 2005 Feb; 2(2):82-8.
     View PubMed
229. Kamm MA, Muller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005 Feb; 100(2):362-72.
     View PubMed
230. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: An overview of available measures. Qual Life Res 2005 Feb; 14(1):21-33.
     View PubMed
231. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol 2005 Feb; 40(3):275-85.
     View PubMed
232. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H-pylori infection: A report on histology and H-pylori detection in the general adult population. Scand J Gastroenterol 2005 Feb; 40(3):302-11.
     View PubMed
233. Locke GR, Zinsmeister AR, Fett SL, Melton LJ, Talley NJ. Overlap of gastrointestional symptom complexes in a US community. Neurogastroenterology & Motility 2005 Feb; 17(1):29-34.
     View PubMed
234. Koloski NA, Boyce PM, Talley NJ. Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci 2005 Jan; 50(1):153-62.
     View PubMed
235. Tuteja AK, Talley NJ, Joos SK, Woehl JV, Hickam DH. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol 2005 Jan; 100(1):124-9.
     View PubMed
236. Talley NJ. Environmental versus genetic risk factors for irritable bowel syndrome: clinical and therapeutic implications. Rev Gastroenterol Disord 2005; 5(2):82-8.
     View PubMed
237. Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: The role of other psychosocial variables. Digestion 2005; 72(2-3):86-96.
     View PubMed
238. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: A randomized, double-blind, placebo-controlled study. Digestion 2005; 72(2-3):97-103.
     View PubMed
239. Talley NJ. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Reviews in Gastroenterological Disorders 2005; 5(1):1-9.
     View PubMed
240. Brandt LJ, Schoenfeld P, Prather CM, Quigley EMM, Schiller LR, Talley NJ. Evidence-based position statement on the management of chronic constipation in North America. Am J Gastroenterol 2005; 100(1 Suppl S):1-4.
241. Brandt LJ, Prather CM, Quigley EMM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005; 100(1 Suppl S):S5-S22.
     View PubMed
242. Talley NJ, Moayyedi P, Vakil N. AGA medical position statement: Evaluation of dyspepsia. Gastroenterology 2005; 129:1756-80.
     View PubMed
243. Talley NJ. Epidemiology, severity, and impact of irritable bowel syndrome. Pract Gastroenterol 2005; 29(4 Suppl):4-12.
244. Halder SLS, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol 2005; 8(4):325-36.
     View PubMed
245. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA, Rentz AM, Dubois D. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res 2004 Dec; 13(10):1751-62.
     View PubMed
246. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004 Dec; 13(10):1737-49.
     View PubMed
247. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, Junghard O, Johansson SE, Wiklund I, Agreus L. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol 2004 Dec; 39(12):1201-8.
     View PubMed
248. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004 Dec; 39(12):1280-8.
     View PubMed
249. Vege SS, Locke GR, Weaver AL, Farmer SA, Melton LJ, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: A population-based study. Mayo Clin Proc 2004 Dec; 79(12):1501-6.
     View PubMed
250. Talley NJ. Management of chronic constipation. Reviews in Gastroenterological Disorders 2004 Win; 4(1):18-24.
251. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 2004 Nov; 127(5):1329-37.
     View PubMed
252. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome a tale of one or two disorders. Aliment Pharmacol Ther 2004 Nov; 20(Suppl 7):40-9.
     View PubMed
253. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Alimentary Pharmacology & Therapeutics 2004 Oct 15; 20(8):909-15.
     View PubMed
254. Cremonini F, Talley NJ. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Minerva Med 2004 Oct; 95(5):427-41.
     View PubMed
255. Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L, de Boer W, Jones R, Malfertheiner P, Agreus L. Management issues in dyspepsia: Current consensus and controversies. Scand J Gastroenterol 2004 Oct; 39(10):913-8.
     View PubMed
256. Haag S, Talley NJ, Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut 2004 Oct; 53(10):1445-51.
     View PubMed
257. Talley NJ. Practical examples: trials and conclusions - an interactive segment. Alimentary Pharmacology & Therapeutics 2004 Oct; 20(Suppl 5):9-13.
     View PubMed
258. Talley NJ. Gastro-oesophageal reflux disease - how wide is its span? Alimentary Pharmacology & Therapeutics 2004 Oct; 20(Suppl 5):27-37.
     View PubMed
259. Dent J, Talley NJ. Clinical strategies - interactive case discussions. Alimentary Pharmacology & Therapeutics 2004 Oct; 20(Suppl 5):97-104.
     View PubMed
260. Crowell MD, Lacy BE, Schettler VA, Dineen TN, Olden KW, Talley NJ. Subtypes of anal incontinence associated with bowel dysfunction: Clinical, physiologic, and psychosocial characterization. Dis Colon Rectum 2004 Oct; 47(10):1627-35.
     View PubMed
261. Rohrbock RBK, Hammer J, Vogelsang H, Talley NJ, Hammer HF. Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: A study in health and IBS. Am J Gastroenterol 2004 Oct; 99(10):1990-7.
     View PubMed
262. Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther 2004 Sep 1; 20(5):497-505.
     View PubMed
263. Friedrich WN, Whiteside SP, Talley NJ. Noncoercive sexual contact with similarly aged individuals: what is the impact? Journal of Interpersonal Violence 2004 Sep; 19(9):1075-84.
     View PubMed
264. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol 2004 Sep; 99(9):1801-6.
     View PubMed
265. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: A birth cohort study. Am J Gastroenterol 2004 Sep; 99(9):1807-14.
     View PubMed
266. Armstrong D, Talley NJ, Lauritsen K, Moum B, Lind T, Tunturi-Hihnala H, Venables T, Green J, Bigard MA, Mossner J, Junghard O. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics 2004 Aug 15; 20(4):413-21.
     View PubMed
267. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol 2004 Aug; 99(8):1572-8.
     View PubMed
268. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil 2004 Aug; 16(4):413-9.
     View PubMed
269. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol 2004 Aug; 18(4):717-33.
     View PubMed
270. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology & Therapeutics 2004 Jul; 20(Suppl 2):23-30.
     View PubMed
271. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther 2004 May 1; 19(9):1025-31.
     View PubMed
272. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004 May 1; 53(5):666-72.
     View PubMed
273. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004 May; 53(Suppl 4):1-24.
     View PubMed
274. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004 May; 13(4):833-44.
     View PubMed
275. Holtmann G, Kutscher SU, Haag S, Langkafel M, Heuft G, Neufang-Hueber J, Goebell H, Senf W, Talley NJ. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - A randomized, double-blind placebo-controlled crossover study. Dig Dis Sci 2004 Apr; 49(4):672-9.
     View PubMed
276. Locke GR, Murray JA, Zinsmeister AR, Melton LJ, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: A population-based case-control study. Mayo Clin Proc 2004 Apr; 79(4):476-82.
     View PubMed
277. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functioncal) dyspepsia. Gastroenterology 2004 Apr; 126(4):971-9.
     View PubMed
278. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil 2004 Apr; 16(2):135-42.
     View PubMed
279. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, Goh KL, Sollano J. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004 Apr; 19(4):357-67.
     View PubMed
280. El-Serag HB, Talley NJ. Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004 Mar 15; 19(6):643-54.
     View PubMed
281. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: A population based nested case-control study. Am J Gastroenterol 2004 Feb; 99(2):350-7.
     View PubMed
282. Halder SLS, Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004 Jan 15; 19(2):233-42.
     View PubMed
283. Eslick GD, Howell SC, Hammer J, Talley NJ. Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther 2004 Jan 1; 19(1):133-40.
     View PubMed
284. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs 2004 Jan; 5(1):55-60.
     View PubMed
285. Talley NJ. Irritable bowel syndrome remains a difficult condition to manage. Drug Benefit Trends 2004; 16(6):313-22.
286. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Reviews in Gastroenterological Disorders 2004; 4(Suppl 2):S3-S10.
     View PubMed
287. Delgado-Aros S, Cremonini F, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol 2004; 7(2):121-31.
     View PubMed
288. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. American Journal of Gastroenterology 2004; 99:17081.
     View PubMed
289. Talley NJ. Functional gastrointestinal disorders. DDW Reviews in Gastroenterological Disorders 2004 Review; 4:144-146.
290. Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, Diaz-Rubio M, Caldwell E, Cucala M, Fueyo A, Talley NJ. Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria. American Journal of Gastroenterology 2004; 99:122-130.
     View PubMed
291. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. American Journal of Medicine 2004; 116:740-8.
     View PubMed
292. De la Loge C, Trudeau E, Marquis P, Revicki D, Rentz AM, Stanghellini V, Talley NJ, Kahrilas P, Tack J, Dubois D. Responsiveness and interpretation of a quality of life questionnaire specific to upper-gastrointestinal disorders. Clinical Gastroenterology and Hepatology 2004; 2:778-786.
     View PubMed
293. Revicki DA, Rentz AM, Tack J, Stanghellini V, Talley NJ, Kahrilas P, de la Loge C, Trudeau E, Dubois D. Responsiveness and interpretation of the patient assessment of Gastrointestinal Symptom Severity Index (PAGI-SYM). Clinical Gastroenterology and Hepatology 2004; 2:769-77.
     View PubMed
294. Xia HHX, Wong BCY, Zhang GS, Yang Y, Wyatt JM, Adams S, Cheung K, Lam SK, Talley NJ. Antralization of gastric incisura is topographically associated with increased gastric epithelial apoptosis and proliferation, but not with CagA seropositivity. Journal of Gastroenterology & Hepatology 2004; 19:1257-63.
     View PubMed
295. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003 Dec 1; 52(12):1703-7.
     View PubMed
296. Saito YA, Talley NJ, Melton LJ, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003 Dec; 15(6):687-94.
     View PubMed
297. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003 Nov; 98(11):2454-9.
     View PubMed
298. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 2003 Nov; 58(5):661-70.
     View PubMed
299. Talley NJ. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol 2003 Oct; 56(4):362-9.
     View PubMed
300. Talley NJ. Dyspepsia. Gastroenterology 2003 Oct; 125(4):1219-26.
     View PubMed
301. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003 Oct; 98(10):2209-18.
     View PubMed
302. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics 2003 Aug 15; 18(4):387-93.
     View PubMed
303. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther 2003 Jun 1; 17(11):1389-97.
     View PubMed
304. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther 2003 May 1; 17(9):1171-8.
     View PubMed
305. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003 May; 98(5):1107-11.
     View PubMed
306. Xia HHX, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM. Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary Pharmacology & Therapeutics 2003 Apr 1; 17(7):935-43.
     View PubMed
307. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 2003 Apr; 98(4):750-8.
     View PubMed
308. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol 2003 Apr; 98(4):789-97.
     View PubMed
309. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15000 Australian adults. Am J Gastroenterol 2003 Feb; 98(2):391-8.
     View PubMed
310. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol 2003 Feb; 98(2):264-71.
     View PubMed
311. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology and Therapeutics 2003; 17:841-51.
     View PubMed
312. Howe SC, Quine S, Talley NJ. Ethics review and use of reminder letters in postal surveys: are current practices comprising an evidence-based approach? Med J Aust 2003; 178:43.
     View PubMed
313. Talley NJ. Functional Disorders. Target the brain to get the gain? Reviews in Gastrointestinal Disorders 2003; 3:182-4.
314. Talley NJ. Best of DDW 2003. New insights on treatment of irritable bowel syndrome and functional dyspepsia Reviews in Gastroenterological Disorders 2003; 3:172-5.
315. Talley NJ. Update on the Role of Drug Therapy in Non-Ulcer Dyspepsia. Reviews in Gastroenterological Disorders 2003; 3:25-30.
     View PubMed
316. Wiklund I, Talley NJ. Update on health-related quality of life in patients with gastroesophageal reflux disease (GERD). Expert Rev Pharmacoeconomics & Outcomes Research 2003; 3:341-50.
317. Dent J, Talley NJ. Overview: initial and long-term management of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 2003; 1(17 Suppl):53-7.
318. Weltman MD, Talley NJ. Chronic hepatitis C infection: a review and update on treatment strategies. ADF Health 2003; 4:27-33.
319. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobactor pylori eradication therapy in non-ulcer dyspepsia. Resolving the discrepancy between systematic reviews. American Journal of Gastroenterology 2003; 98(12):2621-2626.
     View PubMed
320. Talley NJ. Helicobacter pylori management: how to improve the therapeutic confusion in practice. Canadian Journal of Gastroenterology 2003; B:21B-24B.
321. Müller-Lissner S, Koch G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, Lefkowitz M. Subject’s global assess (SGA) of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. Journal of Clinical Epidemiology 2003; 56:310-16.
     View PubMed
322. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting – a population-based study. Alimentary Pharmacology and Therapeutics 2003; 17:1115-1124.
     View PubMed
323. Quan C, Talley NJ, Cross S, Jones M, Hammer J, Giles N, Horowitz M. Development and validation of the diabetes bowel symptom questionnaire. Alimentary Pharmacology and Therapeutics 2003; 17:1179-1187.
     View PubMed
324. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index (GCSI). Alimentary Pharmacology and Therapeutics 2003; 18:141-50.
     View PubMed
325. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Alimentary Pharmacology and Therapeutics 2003; 18:117-124.
     View PubMed
326. Howell S, Poulton R, Caspi A, Talley NJ. Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study Journal of Psychosomatic Research 2003; 55:179-87.
327. Mearin F, Balboa A, Badia X, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. European Journal of Gastorenterology and Hepatology 2003; 15:165-72.
328. Talley NJ. When to conduct testing in patients with suspected irritable bowel syndrome. Reviews in Gastroenterological Disorders 2003; 3 Suppl 3:S18-24.
     View PubMed
329. Talley NJ. Omeprazole was effective in the short term for uninvestigated dyspepsia ACP J Club 2003; 138:1-3.
     View PubMed
330. Weltman M, Talley NJ. An approach to recurrent, non-identifiable GI bleeding. New Ethicals Journal 2003; New Ethicals Journal 2003:57-63.
     View PubMed
331. Cremonini F, Talley NJ. Commentary – The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome by Creed F, Fernandes L, Guthrie E, et al. Br Med J 2003; 8:160.
     View PubMed
332. Xia HH, Zhang GS, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol 2002 Dec; 97(12):3023-31.
     View PubMed
333. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2002 Dec; 97(12):3087-94.
     View PubMed
334. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol 2002 Dec; 97(12):2950-61.
     View PubMed
335. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology 2002 Dec; 123(6):1763-9.
     View PubMed
336. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology 2002 Nov; 123(5):1451-8.
     View PubMed
337. Talley NJ, Moore MG, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Med J Aust 2002 Oct 21; 177(8):423-7.
     View PubMed
338. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci 2002 Oct; 47(10):2222-30.
     View PubMed
339. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002 Sep; 97(9):2290-9.
     View PubMed
340. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002 Sep; 16(9):1641-8.
     View PubMed
341. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002 Sep; 16(9):1677-82.
     View PubMed
342. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 2002 Aug; 37(8):917-23.
     View PubMed
343. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002 Aug; 14(8):857-63.
     View PubMed
344. Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res 2002 May; 11(3):283-91.
     View PubMed
345. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut 2002 May; 50(Suppl 4):iv26-30; discussion iv31-2.
     View PubMed
346. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002 May; 50(Suppl 4):iv72-8; discussion iv79.
     View PubMed
347. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut 2002 May; 50(Suppl 4):iv36-41.
     View PubMed
348. Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci 2002 Apr; 47(4):704-9.
     View PubMed
349. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002 Mar; 97(3):604-11.
     View PubMed
350. Kalantar JS, Howell S, Talley NJ. Prevalence of faecal incontinence and associated risk factors: an underdiagnosed problem in the Australian community? Med J Aust 2002 Jan 21; 176(2):54-7.
     View PubMed
351. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002; 20(11):749-58.
     View PubMed
352. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360:555-64.
     View PubMed
353. Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology 2002; 122:1521-5.
     View PubMed
354. Eslick GD, Coulshed DS, Talley NJ. The burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther 2002; 16:1217-23.
     View PubMed
355. Talley NJ. Dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther 2002; 16(Suppl 4):95-104.
     View PubMed
356. Talley NJ, Quan C. Helicobacter pylori and non-ulcer dyspepsia. Aliment Pharmacol Ther 2002; 16(Suppl 1):58-65.
     View PubMed
357. Waldum HL, Brenna E, Alberti H, Jones R, Dent J, Kahrilas P, Talley NJ. Gastro-oesphageal reflux disease in general practice. Br Med J 2002; 324:485.
358. Axon A, Talley NJ, Veldhuyzen Van Zanten SJ. pH-Hp: implications for dyspepsia management. Gut 2002; 50(Suppl 4):iv1.
     View PubMed
359. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Practice of Clinical Gastroenterology 2002; 16:63-76.
360. Talley NJ, Abeygunasekera S. Bile reflux and Barrett's oesophagus: innocent bystander or sinister companion? Digestive and Liver Disease 2002; 34:246-8.
     View PubMed
361. Abeygunasekera S, Talley NJ. Management of dysepsia. Comprehensive Therapy 2002; 28:182-9.
     View PubMed
362. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother 2002; 3:1301-11.
     View PubMed
363. Friedrich WN, Whiteside SP, Talley NJ. A research perspective on the compliant child victim. APSAC Advisor 2002; 14(2):19-20.
364. Weltmann MD, Talley NJ. An approach to recurrent non-identifiable GI bleeding. Curr Ther 2002; 43:27-35.
365. Coulshed DS, Eslick GD, Talley NJ. Non-cardiac chest pain: patients need diagnoses? Br Med J 2002; 324:915.
     View PubMed
366. Jones R, Dent J, Kahrilas P, Talley NJ. Management of gastro-oesphageal reflux disease in general practice. Br Med J 2002; 322:344-7.
     View PubMed
367. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci 2001 Dec; 46(12):2716-23.
     View PubMed
368. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001 Nov; 36(11):1155-61.
     View PubMed
369. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001 Oct; 96(10):2905-14.
     View PubMed
370. Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther 2001 Oct; 15(10):1603-11.
     View PubMed
371. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001 Oct; 121(4):799-804.
     View PubMed
372. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults. Arch Intern Med 2001 Sep 10; 161(16):1989-96.
     View PubMed
373. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001 Sep; 49(3):395-401.
     View PubMed
374. Talley NJ. Irritable bowel syndrome. Best Practice of Medicine 2001 Sep.
     View PubMed
375. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15000 Australian adults. Gut 2001 Jul; 49(1):66-72.
     View PubMed
376. Holtmann G Gschossmann J Holtmann M Talley NJ . H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci 2001 Jul; 46(7):1550-7.
     View PubMed
377. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001 Jul; 96(7):1998-2004.
     View PubMed
378. Talley NJ, Thitiphuree S. Lump or split dyspepsia? A continuing controversy. Curr Gastroenterol Rep 2001 Jun; 3(3):175-6.
     View PubMed
379. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia. Best Pract Res Clin Gastroenterol 2001 Jun; 15(3):385-400.
     View PubMed
380. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001 May; 96(5):1340-9.
     View PubMed
381. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001 May; 96(5):1422-8.
     View PubMed
382. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol 2001 Apr; 96(4):1139-42.
     View PubMed
383. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001 Apr; 96(4):1072-9.
     View PubMed
384. Talley NJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001 Apr; 96(4):1033-8.
     View PubMed
385. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001 Apr; 96(4):1039-46.
     View PubMed
386. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, Kleoudis C, Mangel AW. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001 Apr; 15(4):525-37.
     View PubMed
387. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol 2001 Mar; 96(3):673-6.
     View PubMed
388. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001 Mar; 96(3):689-96.
     View PubMed
389. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther 2001 Mar; 15(3):347-54.
     View PubMed
390. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther 2001 Feb; 15(2):207-16.
     View PubMed
391. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M, Horowitz M. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001 Jan; 96(1):71-6.
     View PubMed
392. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther 2001 Jan; 15(1):137-42.
     View PubMed
393. Boyce P, Hickey A, Gilchrist J, Talley NJ. The development of a brief personality scale to measure vulnerability to postnatal depression. Archive of Women's Mental Health 2001; 3:147-53.
394. Bensoussan A, Chang SW, Menzies RG, Talley NJ. Application of the general health status questionnaire SF36 to patients with gastrointestinal dysfunction: initial validation and validation as a measure of change. Aust N Z J Public Health 2001; 25(1):71-7.
     View PubMed
395. Dent J, Jones R, Kahrilas PJ, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. Br Med J 2001; 322:344-47.
396. Talley NJ. Commentary on "Community screening for Helicobacter pylori does not improve quality of life.". Evidence Based Healthcare 2001; 5:7.
397. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol 2001; 96:673-6.
398. Talley NJ. Metholdogical issues in irritable bowel syndrome clinical trials: practical relevance for the clinician. Practical Gastroenterology 2001; 8:16-23.
399. Talley NJ. Dealing with patients' concerns and expectations. Eur J Gastroenterol Hepatol 2001; 13(Suppl 3):S5-6.
     View PubMed
400. Talley NJ. Should oesophagitis be healed? Eur J Gastroenterol Hepatol 2001; 13(Suppl 3):S36-7.
401. Talley NJ. Efficacies of different proton pump inhibitors in reflux disease. Eur J Gastroenterol Hepatol 2001; 13(Suppl 3):S55-6.
402. Talley NJ. When and why should empirically treated patients have endoscopy? Eur J Gastroenterol Hepatol 2001; 13(Suppl 3):S75-6.
403. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96:16-26.
     View PubMed
404. Xia HH, Wong BCY, Talley NJ, Lam SK. Helicobacter pylori infection: current treatment practice. Expert Opin Pharmacother 2001; 2:253-66.
     View PubMed
405. Talley NJ, Phung N, Kalantar JS. ABC of the upper gastrointestinal tract: indigestion: when is it functional? Br Med J 2001; 323:1294-7.
406. Talley NJ. Serotinergic neuroenteric modulators. Lancet 2001; 358:2061-8.
     View PubMed
407. Talley NJ. Drug therapy options for patients with irritable bowel syndrome. Am J Manag Care 2001; 7:S261-7.
     View PubMed
408. Bytzer P Talley NJ. Dyspepsia. Ann Intern Med 2001; 134:815-22.
     View PubMed
409. Talley NJ. H. pylori and functional dyspepsia. Gut 2001; 49:738-9.
     View PubMed
410. Koloski NA, Talley NJ, Boyce PM, Morris-Yates AD. The effect of questionnaire length and lottery ticket incentive on the response rate in mail surveys. Psychology & Health 2001; 16:67-75.
411. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther 2000 Dec; 14(12):1581-8.
     View PubMed
412. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000 Dec; 14(12):1653-61.
     View PubMed
413. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust 2000 Nov 20; 173(10):515-9.
     View PubMed
414. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol 2000 Nov; 16(6):503-7.
     View PubMed
415. Nandurkar S, Talley NJ. Epidemiology and natural history of reflux disease. Baillieres Best Pract Res Clin Gastroenterol 2000 Oct; 14(5):743-57.
     View PubMed
416. Saito YA, Locke GR III, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ III. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000 Oct; 95(10):2816-24.
     View PubMed
417. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000 Sep; 75(9):907-12.
     View PubMed
418. Hu WH, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol 2000 Sep; 95(9):2189-94.
     View PubMed
419. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol 2000 Sep; 12(9):981-8.
     View PubMed
420. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut 2000 Sep; 47(3):332-6.
     View PubMed
421. Locke GR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol 2000 Aug; 95(8):1906-13.
     View PubMed
422. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol 2000 Jun; 95(6):1439-47.
     View PubMed
423. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J 2000 May 26; 113(1110):178-81.
     View PubMed
424. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther 2000 May; 14(5):615-24.
     View PubMed
425. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol 2000 Apr; 95(4):878-96.
     View PubMed
426. Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR. Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence Questionnaire. Dis Colon Rectum 2000 Feb; 43(2):146-53; discussion 153-4.
     View PubMed
427. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort and bowel habit descriptors. Scand J Gastroenterol 2000 Feb; 35(2):142-51.
     View PubMed
428. Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis 2000 Feb; 36(2):69-74.
     View PubMed
429. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci 2000 Feb; 45(2):217-24.
     View PubMed
430. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, Mitchell HM. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 2000 Jan; 95(1):114-21.
     View PubMed
431. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000 Jan; 95(1):67-71.
     View PubMed
432. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000 Jan; 95(1):157-65.
     View PubMed
433. Talley NJ. Diagnosis and management of non-ulcer dyspepsia. Primary Care Reports 6(1) 2000 Jan.
434. Pantoflickova D, Blum AL, Talley NJ, Koelz HR. Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Meta-analysis included unreliable studies. Br Med J 2000; 320:1209.
     View PubMed
435. Boyce P, Gilchrist J, Talley NJ, Rose D. Cognitive-behavioural therapy as a treatment for irritable bowel syndrome; a pilot study. Australian and New Zealand Journal of Psychiatry 2000; 34:300-9.
     View PubMed
436. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000; 95:3176-83.
     View PubMed
437. Thitiphuree S, Talley NJ. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract 2000; 54:537-41.
     View PubMed
438. Eslick GD, Talley NJ. Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust 2000; 173:233-4.
     View PubMed
439. Talley NJ. Empirical eradication therapy was better than endoscopy-based management for Helicobacter pylori infection and dyspepsia. ACP Journal Club 2000; 132:46.
440. Westbrook JI, McIntosh JH, Talley NJ. The impact of dyspepsia definition on prevalence estimates: considerations for future researchers. Scand J Gastroenterol 2000; 35:227-33.
     View PubMed
441. Talley NJ. Irritable bowel syndrome: practical management. Aust Fam Physician 2000; 29:893-8.
     View PubMed
442. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol 1999 Nov; 15(6):492.
     View PubMed
443. Xia HH, Gallagher C, Hyde D, Talley NJ, Keane CT, O'Morain CA. Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. Ital J Gastroenterol Hepatol 1999 Nov; 31(8):663-8.
     View PubMed
444. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol 1999 Nov; 52(11):1117-22.
     View PubMed
445. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol 1999 Sep; 94(9):2390-7.
     View PubMed
446. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999 Sep; 94(9):2373-9.
     View PubMed
447. van Zanten SJOV, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 1999 Sep; 45(Suppl 2):69-77.
448. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol 1999 Aug; 11(8):881-6.
     View PubMed
449. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med 1999 Jul 26; 159(14):1592-8.
     View PubMed
450. Talley NJ. Gastro-esophageal reflux disease in adults. How to treat. Australian Doctor 1999 July 2.
451. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc 1999 Jul; 47(7):837-41.
     View PubMed
452. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999 Jun; 106(6):642-9.
     View PubMed
453. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol 1999 Jun; 34(6):566-74.
     View PubMed
454. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J 1999 Mar 27; 318(7187):833-7.
455. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999 Feb; 13(2):225-35.
     View PubMed
456. Bolin TD, Korman MG, Stanton R, Talley NJ, Newstead GL, Donnelly N, Hall W, Ho MT, Lapsley H. Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal Disease 1999; 1:113-22.
457. Lam CM, Kennedy ML, Lubowski DZ, Talley NJ. Prevalence and risk factors for faecal incontinence: a population based study. Colorectal Disease 1999; 1:197-203.
458. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med 1999; 341:1106-11.
     View PubMed
459. Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med 1999; 107(Suppl 5A):5S-11S.
     View PubMed
460. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Clinical Gastroenterology International Practice and Research 1999; 13:371-84.
461. Xia HH, Talley NJ. Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs 1999; 58:785-92.
     View PubMed
462. Xia HH, Fan X-G, Talley NJ. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World Journal of Gastroenterology 1999; 5:263-6.
     View PubMed
463. Talley NJ, Axon A, Bytzer P, Holtmann G, Lam SK, Veldhuyzen van Zanten S. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther 1999; 13:1135-48.
     View PubMed
464. Talley NJ. How should Helicobacter pylori positive dyspeptic patients be managed? Gut 1999; 45(Suppl 1):I28-31.
     View PubMed
465. Talley NJ. Management of dyspepsia and functional dyspepsia: an international perspective. Canadian Journal of Gastroenterology 1999; 13:685-7.
     View PubMed
466. Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointestinal Endoscopy 1999; 50:229-40.
     View PubMed
467. Tytgat G, Hungin APS, Malfertheiner P, Talley NJ, Hongo M, McColl K, Soule JC, Agreus L, Bianchi-Porro G, Freston J, Hunt R. Decision making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol 1999; 11:223-30.
     View PubMed
468. Talley NJ, Stanghellini V, Heading R, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders: a working team report for the Rome II consensus on funtional gastrointestinal disorders. Gut 1999; 45(Suppl 2):II37-42.
     View PubMed
469. Talley NJ, Wingate DL. Irritable bowel syndrome and the role of 5-HT. Aliment Pharmacol Ther 1999; 13(Suppl 2):1-82.
470. Talley NJ. Helicobacter pylori and dyspepsia. Yale Journal of Biology and Medicine 1999; 72:145-51.
     View PubMed
471. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ. An evidence-based appraisal of reflux disease management: the Genval workshop report. Gut 1999; 44(Suppl 2):S1-S16.
     View PubMed
472. Nandurkar S, Talley NJ. Barrett's esophagus: the long and the short of it. Am J Gastroenterol 1999; 94:1719.
     View PubMed
473. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part 1 July 1999.
474. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part 2 July 1999.
475. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part 3 July 1999.
476. Yeomans N, Talley NJ, Lee A, Katelaris P. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute 1999.
477. Kalantar J, Eslick G, Talley NJ. Chronic gastritis and non-ulcer dyspepsia. Curr Top Microbiol Immunol 1999; 241:31-45.
     View PubMed
478. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998 Dec 24; 339(26):1875-81.
     View PubMed
479. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998 Nov 11; 280(18):1585-9.
     View PubMed
480. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998 Nov; 12(11):1055-65.
     View PubMed
481. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol 1998 Nov; 93(11):2179-83.
     View PubMed
482. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998 Nov; 252(3):418-25.
     View PubMed
483. Nandurkar S, Martin CJ, Talley NJ, Wyatt JM. Curable cancer in a short segment Barrett's esophagus. Dis Esophagus 1998 Oct; 11(4):284-7.
     View PubMed
484. Xia HH, Kalantar J, Talley NJ. Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in Western Sydney as determined by testing multiple isolates from different gastric sites. J Gastroenterol Hepatol 1998 Oct; 13(10):1044-9.
     View PubMed
485. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998 Aug; 93(8):1271-6.
     View PubMed
486. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998 Aug; 93(8):1311-7.
     View PubMed
487. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer, and health. Am J Gastroenterol 1998 Aug; 93(8):1222-7.
     View PubMed
488. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not Helicobacter pylori. Arch Intern Med 1998 Jul 13; 158(13):1427-33.
     View PubMed
489. Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther 1998 Jul; 12(7):641-5.
     View PubMed
490. Talley NJ, Chang FY, Wyatt JM, Adams S, Lau A, Borody T, Chen TS, Daskolopolos G, Cheung K, Talley NA, Full-Young C, Tseng-Shing C. Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1998 Jun; 12(6):527-32.
     View PubMed
491. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998 Jun; 47(6):449-54.
     View PubMed
492. Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci 1998 May; 43(5):1016-22.
     View PubMed
493. Talley NJ, Boyce P, Jones M. Identification of distrinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998 May; 42(5):690-5.
     View PubMed
494. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 1998 Apr; 42(4):501-6.
     View PubMed
495. Roberts RO, Jacobsen SJ, Rhodes T, Reilly WT, Girman CJ, Talley NJ, Lieber MM. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc 1998 Apr; 46(4):467-72.
     View PubMed
496. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology 1998 Feb; 51(2):213-9.
     View PubMed
497. Evans JM, Fleming KC, Talley NJ, Schleck CD, Zinsmeister AR, Melton LJ III. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc 1998 Jan; 46(1):83-7.
     View PubMed
498. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population-based study. Gut 1998 Jan; 42(1):47-53.
     View PubMed
499. Junghard O, Lauritsen K, Talley NJ, Wiklund IK. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia. Eur J Surg Suppl 1998; 583:106-11.
     View PubMed
500. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998; 93:2184-90.
     View PubMed
501. Talley NJ, Eslick GD. Commentary on "Eradication of Helicobacter pylori before NSAID treatment prevented ulcers.". ACP Journal Club 1998; 128:44.
502. Talley NJ. Commentary on review: Misoprostol was most cost-effective if risk for NSAID-related GI events was high. Arthritis Rheum 1998; 129:25.
503. Nandurkar S, Talley NJ. Surveillance in Barrett's esophagus: a need for reassessment? J Gastroenterol Hepatol 1998; 13:1069-105.
     View PubMed
504. Talley NJ. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Am J Med 1998; 104:S62-6.
     View PubMed
505. Talley NJ. Scope of the problem of functional digestive disorders. European Journal of Surgery 1998; 164(Suppl 582):135-41.
506. Talley NJ. Irritable bowel syndrome: disease definition and symptom description. Eur J Surg 1998; 164(Suppl 583):24-8.
507. Talley NJ, Silverstein M, Agreus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review-evaluation of dyspepsia. Gastroenterology 1998; 114:582-95.
     View PubMed
508. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus guidelines on the management of H. pylori. J Gastroenterol Hepatol 1998; 13:1-12.
     View PubMed
509. Talley NJ, Hau-Xiang Xia H. Helicobacter pylori infection and non-ulcer dyspepsia. British Medical Bulletin 1998; 54:63-9.
     View PubMed
510. Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol 1998; 93:394-400.
     View PubMed
511. Veldhuyzen van Zanten S, Talley NJ. Should antibiotic treatment of Helicobacter positive patients within non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol 1998; 10:367-70.
     View PubMed
512. Hu WHC, Talley NJ. Functional (non-ulcer) dyspepsia: unexplained but not unmanageable. Med J Aust 1998; 168:507-12.
     View PubMed
513. Hammer J, Talley NJ. Non-ulcer dyspepsia: evaluation (including the role of Helicobacter pylori, the role of dysmotility, and management). Curr Opin Gastroenterol 1998; 14:447-51.
514. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998; (583):41-9.
515. Phung N, Kalantar J, Talley NJ. Management of dyspepsia in general practice. Mod Med 1998; 41:10-18.
516. Talley NJ, O'Connor S. Sistema nervioso: exploracion de los nervios craneales (III). Review Salud Rural 1998; 5:111-30.
517. Talley NJ, Kalantar JS. Unexplained weight loss. Curr Ther 1998; 37-43.
518. Holtmann G, Stanghellini V, Talley NJ. Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. Baillieres Clin Gastroenterol 1998; 12:417-33.
     View PubMed
519. Weltmann M, Talley NJ. The patient with recurrent non-identifiable GI bleeding. Current Therapeutics 1998.
520. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci 1997 Nov; 42(11):2327-32.
     View PubMed
521. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut 1997 Sep; 41(3):394-8.
     View PubMed
522. Talley NA, Chen F, King D, Jones M, Talley NJ. Short chain fatty acids in the treatment of radiation proctitis: a randomized, placebo-controlled crossover trial. Dis Colon Rectum 1997 Sep; 40(9):1046-50.
     View PubMed
523. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis, and associations. Gut 1997 Jun; 40(6):710-5.
     View PubMed
524. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997 Jun; 92(6):954-9.
     View PubMed
525. Friedrich WN, Talley NJ, Panser L, Fett S, Zinsmeister AR. Concordance of reports of childhood abuse by adults. Child Maltreat 1997 May; 2(2):164-71.
526. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 May; 112(5):1448-56.
     View PubMed
527. Frankum B, Talley NJ. The tired listless patient. Curr Ther 1997 Mar; 41-5.
528. Talley NJ, Xia HH. Gastric cancer. An infectious disease? New Zealand Patient Management 1997; 26:9-11.
529. Agreus L, Talley NJ. Dyspepsia: current understanding and management. Annual Review Medicine 1997; 49:475-93.
530. McManis PG, Talley NJ. Nausea and vomiting associated with selective serotonin reuptake inhibitors: incidence, mechanisms, and management. CNS Drugs 1997; 8:394-401.
531. Xia HH, Talley NJ, Keane CT, O'Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature, possible causes, and potential preventive strategies. Dig Dis Sci 1997; 42:1821-34.
     View PubMed
532. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol 1997; 92:1780-7.
     View PubMed
533. Talley NJ, Hunt RH. What role does Helicobacter pylori play in non-ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms Gastroenterology 1997; 113(6 Suppl S):S67-77.
534. Talley NJ. Dyspepsia and heartburn: a clinical challenge. Aliment Pharmacol Ther 1997; 11(Suppl 2):1-8.
     View PubMed
535. Agreus L, Talley N. Dyspepsia management in general practice. Br Med J 1997; 315:1284-8.
536. Holtmann G, Talley NJ, Goebell H. Association between Helicobacter pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci 1996 Jul; 41(7):1285-91.
     View PubMed
537. Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol 1996 Jun; 91(6):1138-44.
     View PubMed
538. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Am J Gastroenterol 1996 Apr; 91(4):660-73.
     View PubMed
539. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 1996 Mar; 91(3):485-91.
     View PubMed
540. Toma TP, Zighelboim J, Phillips SF, Talley NJ. Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat. Neurogastroenterol Motil 1996 Mar; 8(1):19-28.
     View PubMed
541. Talley NJ, Hu WHC. Commentary on "Misoprostol reduced serious NSAID-induced gastrointestinal complications in rheumatoid arthritis.". Ann Intern Med 1996 Mar-Apr; 124:38.
542. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996 Feb; 91(2):277-83.
     View PubMed
543. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996 Jan; 110(1):72-83.
     View PubMed
544. Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, Melton LJ. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996 Jan; 91(1):19-25.
     View PubMed
545. Talley NJ. Modern management of dyspepsia. Aust Fam Physician 1996; 25:47-52.
     View PubMed
546. Hu WHC, Talley NJ. Visceral perception in functional gastrointestinal disorders: disease marker or epiphenomenon? Dig Dis 1996; 4:276-88.
547. Talley NJ. Quality of life in functional dyspepsia. Scand J Gastroenterol 1996; 31(Suppl 221):21-2.
548. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol 1996; 31(Suppl 220):19-22.
549. Xia HH, Talley NJ. Prospects for improved therapy for Helicobacter pylori. (Leading Article). Expert Opin Investig Drugs 1996; 5:959-76.
550. Talley NJ. H. pylori and functional dyspepsia. Excepta Medica 1996; 5-6.
551. Talley NJ. Helicobacter pylori: a role in functional dyspepsia? Motility Clinical Perspective in Gastroenterology 1996; 34:11-12.
552. Talley NJ. The irritable bowel syndrome: the guts of the problem. Resident & Staff Physician 1996; 42:11-16.
553. Talley NJ. Management of peptic ulcer disease. No role for long-term H2RAs. Gastrointestinal Medicine in General Practice 1996; 8:22-5.
554. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican 1996; 14:7-13.
555. Talley NJ. Is there a role for H2 -receptor blockers in the treatment of H. pylori gastritis? The Management of Acid Peptic Disorders: An Asian Perspective 1996; 12:25-9.
556. Talley NJ. Irritable bowel syndrome. Australian Doctor 1996.
     View PubMed
557. Talley NJ, Hu WHC, Holtmann G. Symptoms, investigation and treatment of gastroparesis. Mod Med Aust 1995 Dec; 27-33.
558. Locke GR III, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 1995 Dec; 109(6):1750-6.
     View PubMed
559. Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol 1995 Dec; 90(12):2115-9.
     View PubMed
560. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med 1995 Nov 15; 123(10):782-94.
     View PubMed
561. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995 Aug; 25(4):302-8.
     View PubMed
562. Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995 Jul 1; 142(1):76-83.
     View PubMed
563. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. Journals of Gerontology. Series A, Biological Sciences & Medical Sciences 1995 Jul; 50(4):M184-9.
564. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995 Jun; 40(6):1345-50.
     View PubMed
565. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995 Jun; 40(6):1345-50.
     View PubMed
566. Talley NJ, Hu WHC. Commentary on "Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.". Ann Intern Med 1995 May-Jun; 122:81.
     View PubMed
567. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995 Apr; 40(4):819-27.
     View PubMed
568. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol 1995 Mar; 90(3):366-71.
     View PubMed
569. Talley NJ, Weaver AL, Zinsmeister AR. Impact on functional dyspepsia on quality of life. Dig Dis Sci 1995 Mar; 40:584-589.
     View PubMed
570. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995 Mar; 108(3):917-24.
     View PubMed
571. Talley NJ. Dyspepsia in the elderly. Mod Med Aust 1995 Feb; 72-6.
572. Owens DM, Nelson DK, Talley NJ. Irritable bowel syndrome: long term prognosis and the physician-patient interaction. Ann Intern Med 1995 Jan 15; 122(2):107-12.
     View PubMed
573. Zighelboim J, MacCarty RL, Talley NJ. Abnormalities in the shape of the duodenal loop on X-ray. Associated with idiopathic antral hypomotility? Dig Dis Sci 1995 Jan; 40(1):128-33.
     View PubMed
574. Holtmann G, Guerra G, Huber J, Goebell H, Talley NJ. Perception of gastric distention: influence of the mode of distention on perception thresholds and gastric compliance. Dig Dis Sci 1995; 40:2673-7.
     View PubMed
575. Bolin T, Hunt R, Korman M, Lambert J, Lee A, Talley NJ. Helicobacter pylori and gastric neoplasia: evolving concepts. Med J Aust 1995; 163:253-25.
     View PubMed
576. Talley NJ. Functional dyspepsia: should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9:107-15.
     View PubMed
577. Talley NJ. Management of dyspepsia. Gastrointestinal Diseases Today 1995; 4:11-17.
578. Lambert J, Lee A, Talley NJ, Yeomans N. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute 1995.
579. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994 Oct; 107(4):1040-9.
     View PubMed
580. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol 1994 Aug; 89(8):1160-4.
     View PubMed
581. Zighelboim J, Talley NJ, Phillips SF. Response of gastric fundus to rectal distension in healthy persons. Dig Dis Sci 1994 Jul; 39(7):1441-5.
     View PubMed
582. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ III. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol 1994 Jun; 89(6):843-6.
     View PubMed
583. Grotz RL, Pemberton JH, Talley NJ, Rath DM, Zinsmeister AR. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut 1994 Jun; 35(6):798-802.
     View PubMed
584. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994 Jun; 69(6):539-47.
     View PubMed
585. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut 1994 May; 35(5):619-24.
     View PubMed
586. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994 May; 106(5):1174-83.
     View PubMed
587. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994 May; 39(5):1090-8.
     View PubMed
588. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Curr Ther 1994 May; 55-63.
589. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol 1994 Apr; 89(4):524-8.
     View PubMed
590. Talley NJ. Epidemiology of Helicobacter pylori infection. NIH Consens Statement 1994 Feb 7-9; 12:1-15.
591. Talley NJ. Diagnosis of Helicobacter pylori infection. Infections in Medicine 1994; (Special Supplement):18-26.
592. Talley NJ. Food for thought: the real story behind stomach ulcers. Chem Ind 1994; 7:259-62.
593. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. European Journal of Gastroenterology and Hepatology 1994; 6:917-24.
594. Talley NJ. A relationship between Helicobacter pylori and non-ulcer dyspepsia: is there enough data to know? Eur J Gastroenterol Hepatol 1994; 6:567-70.
595. Talley NJ. Commentary on "Prompt endoscopy was more cost-effective than H2-blockers in dyspepsia.". Ann Intern Med 1994; 121(Suppl 2).
596. Talley NJ. Gastroduodenal motility. Curr Opin Gastroenterol 1994; 10:618-22.
597. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc 1993 Nov; 68(11):1067-73.
     View PubMed
598. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993 Nov; 105:1378-1386.
     View PubMed
599. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 1993 Oct; 7(5):543-51.
     View PubMed
600. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology 1993 Sep; 105(3):781-90.
     View PubMed
601. Zighelboim J, Carpenter HA, Talley NJ. A patient with diarrhea, arthralgias, and fever. Gastroenterology 1993 Sep; 105(3):923-30.
     View PubMed
602. Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs 1993 Jun; 45(6):918-30.
     View PubMed
603. Talley NJ. Non-ulcer dyspepisa: current approaches to diagnosis and management. Am Fam Physician 1 1993 May; 47(6):1407-16.
604. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology 1993 May; 104(5):1310-9.
     View PubMed
605. Locke GR, Talley NJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol 1993 May-Jun; 8(3):279-86.
     View PubMed
606. Zighelboim J, Talley NJ. Viewpoints in digestive diseases: what are functional bowel disorders? Gastroenterology 1993 Apr; 104(4):1196-201.
     View PubMed
607. Talley NJ. The role of Helicobacter pylori in non-ulcer dyspepsia. Gastroenterol Clin North Am 1993 Mar; 22:153-67.
     View PubMed
608. Talley NJ, Kramlinger KG, Burton MC, Colwell LJ, Zinsmeister AR. Psychiatric disorders and childhood abuse in the irritable bowel syndrome. Eur J Gastroenterol Hepatol 1993; 5:647-54.
     View PubMed
609. Thomas DW, Talley NJ, Mahnovski V, Haight M, Sinatra FR. Rectal mucosal major basic protein in infants with dietary protein-induced colitis. Annals of Allergy 1993; 71:66-9.
     View PubMed
610. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569-80.
     View PubMed
611. Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF. The irritable bowel syndrome: toward optimal design of controlled treatment trials. Gastroenterology International 1993; 6:189-211.
612. Talley NJ. Commentations on "Cholecystectomy and the risk for colorectal cancer.". Ann Intern Med 1993; 120(Suppl 1).
613. Talley NJ. The effects of NSAIDs on the gut. Contemp Intern Med 1993; 5:14-28.
     View PubMed
614. Talley NJ. Non-steroidal anti-inflammatory drug-induced gatroduodenopathy. Dear Colleague 1993.
615. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy: the spectrum of POEMS syndrome. N Engl J Med 1992 Dec 31; 327:1919-23.
     View PubMed
616. Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992 Dec; 30(12):3146-50.
     View PubMed
617. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc 1992 Aug; 67(8):732-8.
     View PubMed
618. Talley NJ. Symptom patterns in functional dyspepsia. Eur J Gastroenterol Hepatol 1992 Aug; 4:597-601.
619. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 1992 Aug; 67(8):725-31.
     View PubMed
620. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992 Jul 15; 136(2):165-77.
     View PubMed
621. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology 1992 Jul; 103(1):137-45.
     View PubMed
622. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol 1992 Jul; 47(4):M116-21.
     View PubMed
623. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992 Jun; 102(6):1899-905.
     View PubMed
624. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health. Am J Gastroenterol 1992 May; 87(5):590-4.
     View PubMed
625. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut 1992 Apr; 33(4):541-6.
     View PubMed
626. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc 1992 Apr; 67(4):354-64.
     View PubMed
627. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992 Apr; 102(4 Pt 1):1259-68.
     View PubMed
628. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992 Mar; 102:895-901.
     View PubMed
629. Talley NJ. 5-Hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992; 6:273-89.
     View PubMed
630. Talley NJ. Dyspepsia and functional dyspepsia. Clin Perspect Gastroenterol 1992; 20:4-8.
     View PubMed
631. Talley NJ. Helicobacter pylori infection. Decision Making in GI Disease 1992; 5:1-8.
632. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991 Dec 4; 83(23):1734-9.
     View PubMed
633. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 Oct; 101(4):927-34.
     View PubMed
634. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol 1991 Aug; 29:1635-1639.
     View PubMed
635. O'Keefe E, Talley NJ. The irritable bowel syndrome in the elderly. Gastroenterol Clin North Am 1991 Jun; 20:369-90.
636. O'Keefe E, Talley NJ. Irritable bowel syndrome in the elderly. Clin Geriatr Med 1991 May; 7(2):265-86.
     View PubMed
637. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 1991 Apr; 36(4):435-40.
     View PubMed
638. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci 1991 Feb; 36:142-145.
     View PubMed
639. Talley NJ, Phillips SF, Bruce BK, Zinsmeister AR, Wiltgen C, Melton LJ. Multisystem complaints in patients with the irritable bowel syndrome and functional dyspepsia. Eur J Gastroenterol Hepatol 1991 Jan; 3:71-77.
640. Fich A, Talley NJ, Shorter RG, Phillips SF. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion. Dig Dis Sci 1991 Jan; 36(1):10-4.
     View PubMed
641. Myers MB, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking cardinoid syndrome. Am J Med 1991; 90:646-648.
     View PubMed
642. Smith RC, Talley NJ, Dent OF, Jones M, Waller SL. Exocrine pancreatic function and chronic unexplained dyspepsia. A case control study. International Journal of Pancreatology 1991; 8:253-62.
     View PubMed
643. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International 1991; 4:145-60.
644. Tygat GNJ, Heading RC, Knill-Jones RP, Richter JE, Malagelada JR, Nyren O, Talley NJ. Towards understanding dyspepsia: an update and consensus from an international working party. Scand J Gastroenterol 1991; 26(Suppl 182):1-74.
645. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl 182):47-60.
646. Talley NJ. Spectrum of chronic dyspepsia in the prescence of the irritable bowel syndrome. Scand J Gastroenterol 1991; 26(Suppl 182):7-10.
647. Talley NJ. Non-ulcer dyspepsia: myths and realities. Aliment Pharmacol Ther 1991; 5 (Suppl 1):145-62.
     View PubMed
648. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International 1990 Dec; 3:159-172.
649. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990 Nov; 65(11):1456-79.
     View PubMed
650. Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology 1990 Aug; 99(2):327-33.
     View PubMed
651. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci 1990 Jul; 35(7):879-84.
     View PubMed
652. MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol 1990 Summer; 15(3):183-7.
     View PubMed
653. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990 Apr; 35(4):477-80.
     View PubMed
654. Ormand JE, Talley NJ. Helicobacter pylori: controversies and an approach to management. Mayo Clin Proc 1990 Mar; 65(3):414-26.
     View PubMed
655. Fich A, Talley NJ, Shorter RG, Phillips SF. Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc 1990 Feb; 65(2):187-91.
     View PubMed
656. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990 Jan; 31:54-58.
     View PubMed
657. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990 Jan; 31(1):77-81.
     View PubMed
658. Pym B, Sandstad J, Seville P, Byth K, Middleton WRJ, Talley NJ, Piper DW. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology 1990; 99:27-35.
     View PubMed
659. Talley NJ. A practical approach to dyspepsia. Contemp Intern Med 1990; 25-33.
660. Talley NJ. Helicobacter pylori and chronic gastroduodenal disease. Infectious Diseases Newsletter 1990; 9:65-7.
661. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ 3rd. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med 1989 Nov 1; 111(9):738-42.
     View PubMed
662. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989 Oct 15; 111(8):671-4.
     View PubMed
663. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology 1989 Sep; 97(3):775-7.
     View PubMed
664. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, Ciociola A. Effect of a selective 5HT3 antagonist (GR-38032F) on small intestinal transit and release of gastrointestinal peptides. Dig Dis Sci 1989; 34:1511-1515.
     View PubMed
665. Talley NJ. Chronic (nonerosive) gastritis: pathogenesis and management. Dig Dis 1989; 7(2):61-75.
     View PubMed
666. Talley NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW. Lack of association between gastric emptying of solids and symptoms in non-ulcer dyspepsia. J Clin Gastroenterol 1989; 11:625-30.
     View PubMed
667. Ormand JE, Talley NJ. Campylobacter pylori, mucus, and peptic ulceration: a dynamic interaction. J Clin Gastroenterol 1989; 11:492-5.
     View PubMed
668. Talley NJ, Ormand JE. Is antibacterial therapy against Campylobacter pylori useful in the therapy of indigestion and chronic peptic ulceration? Trends in Pharmacological Sciences 1989; 10:36-40.
     View PubMed
669. Talley NJ, Kellow JE, Piper DW. Non-ulcer dyspepsia: a management plan. Curr Ther 1989; 30:91-103.
670. Talley NJ. Upper gastrointestinal distress: guidelines for empirical treatment and investigation. Med Times 1989; 117:25-8.
671. Talley NJ. Campylobacter pylori and chronic peptic ulceration: do bugs cause ulcers? Asociacion de Medicina Interna de Mexico, AC. Clinicas Medicas Mexicanas. Curso Internacional de Medicina Interna 1989; 3:5-7.
672. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988 Dec; 63(12):1176-80.
     View PubMed
673. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988; 108:865-79.
     View PubMed
674. Talley NJ, Jones M, Piper DW. Psychosocial and childhood factors in essential dyspepsia. A case control study. Scand J Gastroenterol 1988; 23:341-6.
     View PubMed
675. Talley NJ, McNeil D, Piper DW. Environmental factors and chronic unexplained dyspepsia: association with acetaminophen but not other analgesics, alcohol, coffee, tea, or smoking. Digestive Diseases and Sciences 1988; 33:641-8.
     View PubMed
676. Talley NJ, Ellard K, Jones M, Tennant C, Piper DW. Suppression of emotions in essential dyspepsia and chronic duodenal ulcer: a case control study. Scand J Gastroenterol 1988; 23:337-40.
     View PubMed
677. Talley NJ, Eckstein RP, Gattas MR, Stiel D. Acute hepatitis and Brucella melitensis infection: clinicopathological findings. Medical Journal of Australia 1988; 148:587-90.
     View PubMed
678. Talley NJ, Roth A, Woods J, Hench V. Diagnostic value of liver biopsy in alcoholic liver disease. Journal of Clinical Gastroenterology 1988; 10:647-50.
     View PubMed
679. Talley NJ, McNeil D, Hayden A, Colreavy C, Piper DW. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed non-ulcer dyspepsia. Gastroenterology 1987; 92:1060-6.
     View PubMed
680. Talley NJ, McNeil D, Piper DW. Discriminant value of dyspeptic symptoms. A study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut 1987; 28:40-6.
     View PubMed
681. Talley NJ, Piper DW. A prospective study of social factors and major life event stress in patients with dyspepsia of unknown cause. Scand J Gastroenterol 1987; 22:268-72.
     View PubMed
682. Talley NJ. Non-ulcer dyspepsia. Medical Progress 1987; 31-41.
683. Talley NJ, Piper DW. Comparison of the clincial features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease. Australian and New Zealand Journal of Medicine 1986; 16:352-9.
     View PubMed
684. Talley NJ, Piper DW. Major life event stress and dyspepsia of unknown cause: a case control study. Gut 1986; 27:127-34.
     View PubMed
685. Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91:149-56.
     View PubMed
686. Talley NJ, Fung LH, Gilligan IJ, McNeil D, Piper DW. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case control study. Gastroenterology 1986; 90:886-92.
     View PubMed
687. Fung LH, Gilligan IJ, Talley NJ, Piper DW. Chronic duodenal ulcer, marital status, and personality pattern: a case control study. Journal of Gastroenterology and Hepatology 1986; 1:251-6.
688. Talley NJ. Dyspepsia and non-ulcer dyspepsia: an historical perspective. Med J Aust 1986; 145:614-8.
     View PubMed
689. Talley NJ. Non-ulcer dyspepsia: what measures help? Curr Ther 1986; 27:81-97.
690. Talley NJ. Are symptoms really useful in diagnosing the cause of dyspepsia? Mod Med Aust 1986; 29-31.
691. Piper DW, Talley NJ, Ellard K. Long-term (maintenance) treatment of chronic peptic ulcer. Mod Med Aust 1986; 18-21.
692. Talley NJ, Piper DW. The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scandinavian Journal of Gastroenterology 1985; 20:896-900.
     View PubMed
693. Palmer FJ, Talley NJ. Erdheim-Chester disease with bilateral exophthalmus and liver cell adenoma. Australasian Radiology 1984; 28:305-10.
     View PubMed